Latest Information Update: 03 Nov 2003
At a glance
- Originator Servier
- Class Antipsychotics
- Mechanism of Action Glycine NMDA-associated agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 03 Nov 2003 No development reported - Preclinical for Schizophrenia in France (unspecified route)
- 23 Jan 2001 Preclinical development for Schizophrenia in France (Unknown route)